Population
Human blood platelets
Design
Preclinical
Authors
Loading...
Hypothesis-generating for ADP receptor modulation in platelets; animal data leave open human applicability.
The 2',3'-dialdehyde and dialcohol derivatives of ADP and ATP modulate human platelet aggregation and shape change, with orADP acting as a classical ADP receptor antagonist.
Pearce et al. (1978) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: